Concourse Financial Group Securities, Inc. Intra Cellular Therapies, Inc. Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding ITCI
# of Institutions
414Shares Held
70.6MCall Options Held
409KPut Options Held
158K-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$428 Million1.36% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$402 Million3.71% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$322 Million4.06% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...